Skip to main content
Figure 9 | Breast Cancer Research

Figure 9

From: Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway

Figure 9

Levels of progesterone receptor (PR) in mammary glands obtained from parous rats treated with insulin-like growth factor (IGF)-I (P-IGF-I), untreated parous rats (P-Un), and age-matched virgin rats (AMV). The IGF-I treatment (0.66 mg/kg body weight/day) was continued for 7 days before samples were collected. Protein samples (50 μg/lane) were electrophorized on a 7.5% SDS-PAGE; Western blot analysis was carried out using a specific anti-PR antibody (no. A 0098; DakoCytomation Inc., Carpinteria, CA, USA) and specific protein bands detected using enhanced chemiluminescence reagents. The upper image shows the results of the Western blot analysis and the bar chart shows the quantitation and statistical analysis of the results. Values are expressed as mean ± standard error. *P < 0.05 versus P-Un and AMV.

Back to article page